POSTER: ABCL-612 Real-World Outcomes in Patients With Relapsed or Refractory (r/r) Aggressive Large B-Cell Lymphoma (LBCL) Treated With Chemo-Immunotherapy
Clinical Lymphoma, Myeloma & Leukemia(2023)
关键词
hematologic malignancy,non-Hodgkin lymphoma,large B-cell lymphoma,chemo-immunotherapy,real-world outcomes
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要